Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 8

  • REVIEW ARTICLE

    • Zebrafish live imaging: a strong weapon in anticancer drug discovery and development

      Tiancheng Zhan, Wanqian Song, Guo Jing, Yongkang Yuan, Ning Kang, Qiang Zhang

      • Resumen

      págs. 1807-1835

      

    • Fertility preservation in hematological cancer patients

      Dan Li, Yi jun Zhao, Qian Wang, Man wei Chu, Juan ke Xie, Cui lian Zhang

      • Resumen

      págs. 1836-1843

      

    • Sarcopenia among treated cancer patients before and after neoadjuvant chemotherapy: a systematic review and meta‐analysis of high‑quality studies

      Yuanhao Su, Yongke Wu, Cheng Li, Tingkai Sun, Yunhao Li, Zhidong Wang

      • Resumen

      págs. 1844-1855

      

  • SPECIAL ARTICLE

    • Genomic ancestry and cancer among Latin Americans

      Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Sandra Franco, Natalia Sánchez, Andrés Felipe Cardona, Óscar Arrieta, Luis Alberto Corrales Rodríguez, Claudio Martín, Luis RAEZ, Christian Rolfo

      • Resumen

      págs. 1856-1871

      

  • RESEARCH ARTICLE

    • Partial‑accelerated irradiation with stereotactic radiotherapy at a dose of 30 Gy in 5 fractions in early breast cancer

      Javier Albendea Roch, Javier Tomás Anchuelo Latorre, M. Piedad Galdós Barroso, Paola Andrea Navarrete Solano, Ana Laura Rivero Pérez, Frandeina Pinto Guevara, Mara García Lamela, Javier Olloqui Urroz, Pedro José Prada Gómez, M. Díaz de Tuesta, Jesús Mazaira, Pedro Muñoz

      • Resumen

      págs. 1872-1877

      

    • Effect of HER2/CEP17 ratio on survival in metastatic HER2‑positive gastric cancer, multicenter study

      Serhat Sekmek, Irfan Karahan, Gokhan Ucar, Furkan Ceylan, Dogan Bayram, Ismet Seven, Burak Civelek, Bulent Yalcin, Dogan Uncu, Hatice Bölek, Yüksel Ürün, Kadriye Bir Yücel, Ozan Yazici, Ahmet Kadioglu, Cengiz Karacin, Kubra Canaslan, Elif Atag, Serhat Demirer, Gokmen Umut Erdem, Yakup Ergun, Mehmetcan Atak, Baris Koksal, Merve Meryem Kiran, Duriye Ozer Turkay

      • Resumen

      págs. 1878-1885

      

    • Identification of a gene expression signature associated with brain metastasis in colorectal cancer

      Marlies Michl, Volker Heinemann, Michael S. von Bergwelt Baildon, Tobias Marcus Herold, Frederick Klauschen, Francesco Taverna, Christine Woischke, Pan Li, Thomas Kirchner, Jörg Kumbrink, Jens Neumann, Arndt Stahler, Vindi Jurinovic, Jutta Engel

      • Resumen

      págs. 1886-1895

      

    • Hypertension as predictive factor for bevacizumab‑containing first‑line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011‑04) study

      Álvaro Rodríguez Lescure, Javier Gallego Plazas, Raúl Márquez Vázquez, Lourdes Calvo Martínez, Pedro Sánchez Rovira, A. Antón Torres, José Ignacio Chacón López Muñiz, José Ponce Lorenzo, María José Escudero, Rosalia Caballero Velazquez, Susana Bezares, Pilar García Alfonso, Bartomeu Massuti Sureda, Sara Encinas García, Rosario Dueñas, Vicente Alonso Orduña, Eva Ciruelos, Luis Robles Díaz, Ana Santaballa Bertrán, Jorge Aparicio Urtasun, Manuel Valladares Ayerbes, Juan Rafael Haba Rodríguez

      • Resumen

      págs. 1896-1907

      

    • Patterns of immunotherapy utilization for non‑small cell lung cancer in Texas pre‑ and post‑regulatory approval

      Olajumoke Adenike Olateju, Zhen Zeng, Marjan Zakeri, Sujit S Sansgiry

      • Resumen

      págs. 1908-1920

      

    • The diagnostic and prognostic value of exosomal microRNAs in lung cancer: a systematic review

      Bingbing Yang, Bangshun He, Xiaoqing Cao, Lubanga Nasifu, Zhenlin Nie

      • Resumen

      págs. 1921-1933

      

    • Variation of peripheral blood‑based biomarkers for response of anti‑PD‑1 immunotherapy in non‑small‑cell lung cancer

      Xiaoting Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan

      • Resumen

      págs. 1934-1943

      

    • Computed tomography‑based radiomics nomogram for predicting therapeutic response to neoadjuvant chemotherapy in locally advanced gastric cancer

      Wenjing Chen, Weiteng Zhang, Yiqi Cai, Jun Chen, Jinji Jin, Xietao Chen, Weisong Dong

      • Resumen

      págs. 1944-1955

      

    • Contouring aid tools in radiotherapy. Smoothing: the false friend

      Jordi Marruecos Querol, María Aránzazu Eraso Urién, Diego Jurado, Anna Lopez Vidal, J. Rubió Casadevall, Ricard Mesía Nin, Maria Buxó Pujolràs

      • Resumen

      págs. 1956-1967

      

    • Bevacizumab improved prognosis for advanced EGFR‑mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy

      Yuanliang Zhou, Guangchuan Deng, Qi Wang, Hongyue Qin, Jianbin Li, Yankang Li, Zhenxiang Li, Jingchao Li

      • Resumen

      págs. 1968-1975

      

    • Plasma ctDNA enhances the tissue‑based detection of oncodriver mutations in colorectal cancer

      Wei Wang, Yisen Huang, Jianqiao Kong, Lin Lu, Qianxiu Liao, Jingtao Zhu, Tinghao Wang, Linghua Yan, Jie-min Dai, Zhan Chen, Jun You

      • Resumen

      págs. 1976-1987

      

    • Circulating serum exosomes i‑tRF‑AspGTC and tRF‑1‑SerCGA as diagnostic indicators for non‑small cell lung cancer

      Jiefei Peng, Yue Zhang, Guangfei Zhou, Zhijun Zhang, Luolin Shao, Lin Li

      • Resumen

      págs. 1988-1997

      

    • Clinical risk prediction model and external validation of positive surgical margin in laparoscopic radical prostatectomy based on MRI lesion location

      Xin Chen, Chaozhong Wang, Chengbo Qian, Yuxin Lin, Jianquan Hou, Yuhua Huang, Xuedong Wei, Yongchang Chen, Renpeng Huang, Jie Bao

      • Resumen

      págs. 1998-2005

      

    • Efficacy and safety of anlotinib plus anti‑PD‑1 agents in patients with refractory advanced biliary tract cancers

      Tianqi An, Jian-Hong Zhong, Shuang Hu, Yiyi Liu, Ruihua Zhao, Qiu Hu, Lihua Liu, Xinguang Cao, Rui Li, Jian Li

      • Resumen

      págs. 2006-2019

      

    • Assessment of TUFT1 and Rac1‑GTP levels in triple‑negative breast cancer patients: clinical and pathological correlations

      Su fang Shi, Shuo Li, Xiao-Dong Jiang, Rui xi Cai, Yan fei Ren, Yong Li, Tian lu Yin, Jun Li

      • Resumen

      págs. 2020-2024

      

    • Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single‑cell and bulk RNA‑sequencing data

      Ji-Yan Liu, Guangyu Bai, Qilin Huai, Yuan Li, Xiaowei Chen, Bolun Zhou, Shugeng Cao, Fenglong Bie

      • Resumen

      págs. 2025-2036

      

    • The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta‑analysis

      Miaomiao Wang, Liang Cao, Yanzhong Wang, Hongliang Huang, Junqiang Lei, Xiaoxue Tian

      • Resumen

      págs. 2037-2046

      

    • Prognostic value of dynamic changes of pre‑ and post‑operative tumor markers in colorectal cancer

      Guangming Ren, Gaozan Zheng, Kunli Du, Hanjun Dan, Xinyu Dou, Lili Duan, Zhenyu Xie, Liaoran Niu, Ye Tian, Jianyong Zheng, Fan Feng, Zhangfeng Dang

      • Resumen

      págs. 2047-2059

      

  • BRIEF RESEARCH ARTICLE

    • Management of early‑stage HER2‑positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey

      Olga Martínez, Aleix Prat, Javier Cortés, Eva Ciruelos, Mercedes Marin Aguilera, Gloria González, Laia Paré Brunet, Ivett Adriana Herrera Zuleta, Patricia Villagrasa González, Miguel Martín Jiménez

      • Resumen

      págs. 2060-2069

      

    • Comparative study of weekly and three‑weekly neoadjuvant carboplatin in triple‑negative breast cancer: retrospective analysis in real‑world settings

      Ana Isabel Martin Quesada, Natalia Rodríguez Pérez, Alicia Herrero Márquez, Isaac Núñez Hernández, Elisenda Llabres Valentí, Cristina María Montesdeoca Godoy, Carla M. Martín Abreu, Cristina Alemán Sánchez, Josefina Cruz Jurado, María Hernández Sosa, Melody Marrero García, Cristina V. del Pino Hernández, Samuel Hernández Sarmiento, Alejandra Rodríguez Capote, Lina I. Pérez Méndez

      • Resumen

      págs. 2070-2074